You just read:

Pharming Announces FDA Acceptance for Review of Supplemental Biologics License Application for RUCONEST® for Prophylaxis of Hereditary Angioedema Attacks

News provided by

Pharming Group N.V.

17 Jan, 2018, 06:00 GMT